BCG-iv Induces Innate Immune Protection Against M. tuberculosis
Cell publication on how BCG induces innate immune protection against M. Tuberculosis
According to the WHO, respiratory disorders are leading causes of death world-wide (second only to heart attack & stroke). These include diseases such as obstructive lung diseases and pulmonary infections. As a result, our research is focused around four main pulmonary research themes. These include: chronic airways disease, lung injury and infection, neuromuscular dysfunction in respiratory diseases, and sleep-disordered breathing.
Above all, a multidisciplinary approach is used to study the basic mechanisms of a number of diseases. These include asthma, chronic obstructive pulmonary disease, pulmonary infections, cystic fibrosis, sleep apnea, respiratory muscle disorders, pulmonary fibrosis, lung injury, and rare respiratory diseases. Research at the Meakins also involves the study of human physiology and tissues in parallel with relevant animal and cell culture models. Furthermore, research is facilitated by the availability of a variety of core facilities for both clinical and fundamental studies.
Learn more about our research themes here.
Below you will see posts and news items related to our research themes.
Cell publication on how BCG induces innate immune protection against M. Tuberculosis
New funding to Dr. Carolyn Baglole to study human antigen R (HUR) in pulmonary fibrosis.
Scientists discover peptide that could reduce the incidence of RSV-related asthma.
New study is helping children with milk allergies build up tolerance to milk protein
New study sheds light on the importance of newborn screening for Cystic Fibrosis patients
Exercise can lower the risk of muscle wasting associated with aging.
Potential vaccine redirects the immune response away from developing allergies
Arnold Kristof participates in the 2015 TSC Research Challenge
New publication showing Pseudomonas variants in Cystic Fibrosis.
New trial is changing how we approach peanut allergies.